This site is intended for healthcare professionals only
LoginRegister
Vadodara Family Seeks Answers After Young Girl Dies Following Syrup Intake700 plus cough syrup makers under scrutiny after child deaths in MP: Anupriya Patel
ED attaches Rs 2.58 crore assets in corruption case linked to Himachal Assistant Drug ControllerED attaches Rs 2.58 crore assets in corruption case linked to Himachal Assistant Drug Controller
JnJ Imaavy gets European Commission approval for generalised myasthenia gravisJnJ Imaavy gets European Commission approval for generalised myasthenia gravis
Strides Pharma Science: Nandini Matiyani joins as Executive VP - Human ResourcesStrides Pharma Science: Nandini Matiyani joins as Executive VP - Human Resources
Setback to Sun Pharma as Fibromun, Nidlegy Trials Miss Key Endpoints in Cancer StudiesBig investment push: Sun Pharma Labs to set up Rs 3000 crore facility in MP
US FDA approves Denalis genetic disorder therapy for childrenAstrazeneca Baxdrostat application accepted for priority review by USFDA for hard-to-control...
Alkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type 2 DiabetesAlkem Gets CDSCO Panel Nod to Market Synthetic Semaglutide Injection in Multiple Strengths for Type...
Jharkhand Health Dept Moves to Derecognise 34 D.Pharm Colleges Over NOC, Infrastructure LapsesUnaccounted Pregabalin Stock Seized in FDA Raid: Amritsar Chemist Loses License
NPPA Notifies New MRP for Key Cardiac, Diabetes and Antibiotic Drugs, DetailsNPPA Notifies New MRP for Key Cardiac, Diabetes and Antibiotic Drugs, Details
Aurobindo Pharma arm to acquire 20% additional ownership in Luoxin Aurovitas for Rs 45 croreSAI Parenteral buys controlling stake in Noumed Pharma for Rs 125 crore
Jubilant Pharmova ropes in Daniel J OConnor as CEO of Proprietary Novel drugs businessJubilant Pharmova ropes in Daniel J O'Connor as CEO of Proprietary Novel drugs business
SPARC Bags USFDA Rare Pediatric Disease Priority Review Voucher for SezabyUS District Court grants summary judgement in favour of SPARC for Sezaby PRV
X